×

Cramer's Stop Trading: 'Amazed' with GW Pharma

9:51 AM ET Mon, 30 June 2014

CNBC's Jim Cramer explains why he continues to watch the potential market size for GW Pharmaceuticals' orphan drug Epidiolex.